Atlas Venture — 2014 Investments
1 investments dated 2014 · listed companies and verified rows first · show all
Antegrin TherapeuticsDec 2014SEC filinghigh confidence
BiotechSt. Louis, US
Charles Bolten(Director)George H. Capps, II(Executive Officer)Robert Karr(Executive Officer, Director)Michael A. Yeadon(Director)David W. Griggs(Director)Thomas P. Cirrito(Director)
Board seatPeter BarrettRajesh Devraj· per SEC Form D · $26M raise · filed Aug 2017
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.